MedCap AB Statistics

Total Valuation

MedCap AB has a market cap or net worth of SEK 5.87 billion. The enterprise value is 5.86 billion.

Market Cap	5.87B
Enterprise Value	5.86B

Important Dates

The last earnings date was Friday, January 31, 2025.

Earnings Date	Jan 31, 2025
Ex-Dividend Date	n/a

Share Statistics

MedCap AB has 14.97 million shares outstanding. The number of shares has decreased by -0.21% in one year.

Current Share Class	n/a
Shares Outstanding	14.97M
Shares Change (YoY)	-0.21%
Shares Change (QoQ)	-0.64%
Owned by Insiders (%)	4.21%
Owned by Institutions (%)	58.35%
Float	11.38M

Valuation Ratios

The trailing PE ratio is 28.01 and the forward PE ratio is 25.45.

PE Ratio	28.01
Forward PE	25.45
PS Ratio	3.22
PB Ratio	4.58
P/TBV Ratio	9.54
P/FCF Ratio	18.44
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 16.65, with an EV/FCF ratio of 18.42.

EV / Earnings	28.27
EV / Sales	3.25
EV / EBITDA	16.65
EV / EBIT	24.76
EV / FCF	18.42

Financial Position

The company has a current ratio of 2.77, with a Debt / Equity ratio of 0.28.

Current Ratio	2.77
Quick Ratio	1.96
Debt / Equity	0.28
Debt / EBITDA	1.02
Debt / FCF	1.12
Interest Coverage	15.08

Financial Efficiency

Return on equity (ROE) is 18.08% and return on invested capital (ROIC) is 10.09%.

Return on Equity (ROE)	18.08%
Return on Assets (ROA)	8.10%
Return on Invested Capital (ROIC)	10.09%
Return on Capital Employed (ROCE)	14.27%
Revenue Per Employee	3.25M
Profits Per Employee	373,022
Employee Count	556
Asset Turnover	0.99
Inventory Turnover	2.75

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -0.38% in the last 52 weeks. The beta is 0.60, so MedCap AB's price volatility has been lower than the market average.

Beta (5Y)	0.60
52-Week Price Change	-0.38%
50-Day Moving Average	491.02
200-Day Moving Average	519.76
Relative Strength Index (RSI)	37.20
Average Volume (20 Days)	62,048

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, MedCap AB had revenue of SEK 1.81 billion and earned 207.40 million in profits. Earnings per share was 14.00.

Revenue	1.81B
Gross Profit	1.06B
Operating Income	236.80M
Pretax Income	261.60M
Net Income	207.40M
EBITDA	352.20M
EBIT	236.80M
Earnings Per Share (EPS)	14.00

Full Income Statement

Balance Sheet

The company has 370.10 million in cash and 358.00 million in debt, giving a net cash position of 12.10 million or 0.81 per share.

Cash & Cash Equivalents	370.10M
Total Debt	358.00M
Net Cash	12.10M
Net Cash Per Share	0.81
Equity (Book Value)	1.29B
Book Value Per Share	85.62
Working Capital	585.90M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 360.00 million and capital expenditures -41.70 million, giving a free cash flow of 318.30 million.

Operating Cash Flow	360.00M
Capital Expenditures	-41.70M
Free Cash Flow	318.30M
FCF Per Share	21.26

Full Cash Flow Statement

Margins

Gross margin is 58.51%, with operating and profit margins of 13.11% and 11.48%.

Gross Margin	58.51%
Operating Margin	13.11%
Pretax Margin	14.48%
Profit Margin	11.48%
EBITDA Margin	19.49%
EBIT Margin	13.11%
FCF Margin	17.62%

Dividends & Yields

MedCap AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.21%
Shareholder Yield	0.21%
Earnings Yield	3.53%
FCF Yield	5.42%

Stock Splits

The last stock split was on September 27, 2016. It was a reverse split with a ratio of 0.1.

Last Split Date	Sep 27, 2016
Split Type	Reverse
Split Ratio	0.1

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a